Reply letter to the editor concerning the article 'Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance'

• 主要な著者: Elsa Izquierdo-Garcia (著者), Elena Alba Alvaro Alonso (著者), Berta Montero Pastor (著者), Ana Such Díaz (著者), Ismael Escobar Rodríguez (著者)
• フォーマット: 図書
• 出版事項: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

According to the current European medicines legislation, on the labeling is mandatory a warning contraindicating for hereditary fructose intolerance (HFI) patients medicines with oral or parenteral fructose and sorbitol, and oral sucrose, invert sugar, isomaltitol, lactitol and maltitol, but parente...